• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

几种单功能烷化剂对L1210白血病的诱变及化疗活性。

Mutagenic and chemotherapeutic activity in L1210 leukemia of several monofunctional alkylating agents.

作者信息

Schmid F A, Otter G M, Mehta B M

出版信息

Cancer Res. 1985 Jan;45(1):40-4.

PMID:3965147
Abstract

The mutagenic and chemotherapeutic activities of the following monofunctional alkylating agents were compared in vivo: beta-chloroethylamine, dimethyl- and diethylaminoethyl chloride; methyl- and ethylmethanesulfonate; methyl- and ethylnitrosourea; and procarbazine. The bifunctional alkylating agent diethylamine 2,2'-dichloro-N-methyl-hydrochloride was used as reference. The alkylating activity was assessed by reacting with 4-(p-nitrobenzyl)pyridine, and antitumor activity was determined against L1210 in vitro and in vivo. The L1210 response, which is consistent with useful alkylating reactivity, was very marked with the two nitrosoureas and procarbazine. The nitrosoureas and, to some extent, procarbazine decreased the tumorigenicity of L1210 leukemia as evidenced by the increase in survival times with increasing numbers of treatment generations. After treatment for about five transfers (10(6) cells i.p.) with methylnitrosourea (40 mg/kg i.p. on Days 1, 3, and 5), the untreated control mice consistently survived free of tumor, whereas the treated mice died before Day 30. After treatment with ethylnitrosourea (80 mg/kg), the survival times also increased but more in the treated than in the corresponding control groups. Methylnitrosourea was most efficient in increasing the survival times and abolishing tumor transplantability. Antigenic change and loss of growth potential presumably were the reason for this increase in survival time, as indicated by tests in X-irradiated and nude mice. The fact that nitrosoureas and triazenes, besides reducing tumorigenicity, have similarities in their chemistry in that they decompose or are metabolically converted into diazohydroxides and then to carbonium ions is possibly of significance.

摘要

对以下单功能烷化剂的诱变和化疗活性进行了体内比较

β-氯乙胺、二甲基和二乙氨基乙基氯;甲磺酸甲酯和乙酯;甲基和乙基亚硝基脲;以及丙卡巴肼。双功能烷化剂2,2'-二氯-N-甲基-盐酸二乙胺用作对照。通过与4-(对硝基苄基)吡啶反应评估烷化活性,并在体外和体内测定对L1210的抗肿瘤活性。L1210反应与有用的烷化反应性一致,在两种亚硝基脲和丙卡巴肼中非常明显。亚硝基脲以及在一定程度上丙卡巴肼降低了L1210白血病的致瘤性,这通过随着治疗代数增加存活时间的延长得到证明。在用甲基亚硝基脲(第1、3和5天腹腔注射40mg/kg)处理约五次传代(腹腔注射10(6)个细胞)后,未处理的对照小鼠一直存活且无肿瘤,而处理过的小鼠在第30天前死亡。用乙基亚硝基脲(80mg/kg)处理后,存活时间也增加了,但处理组比相应对照组增加得更多。甲基亚硝基脲在延长存活时间和消除肿瘤移植性方面最有效。抗原变化和生长潜能丧失可能是存活时间增加的原因,X射线照射小鼠和裸鼠的试验表明了这一点。亚硝基脲和三氮烯除了降低致瘤性外,在化学性质上有相似之处,即它们分解或代谢转化为重氮氢氧化物,然后转化为碳正离子,这一事实可能具有重要意义。

相似文献

1
Mutagenic and chemotherapeutic activity in L1210 leukemia of several monofunctional alkylating agents.几种单功能烷化剂对L1210白血病的诱变及化疗活性。
Cancer Res. 1985 Jan;45(1):40-4.
2
Drug sensitivity of methylnitrosourea- and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea-resistant L1210 lines.甲基亚硝基脲和1-(2-氯乙基)-3-(反式-4-甲基环己基)-1-亚硝基脲抗性L1210细胞系的药物敏感性
Cancer Res. 1986 Sep;46(9):4469-71.
3
Mutagenic and chemotherapeutic activity in L1210 leukemia of several monofunctional alkylating agents.
Cancer Res. 1985 Jul;45(7):3400-2.
4
Comparison of mutagenicity, antitumor activity, and chemical properties of selected nitrosoureas and nitrosoamides.
Cancer Res. 1979 Apr;39(4):1328-33.
5
Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.药物敏感和耐药的L1210白血病对大剂量化疗的反应。
Cancer Res. 1987 May 1;47(9):2323-7.
6
Pharmacological and preclinical toxicological studies of 1,2-diaminocyclohexane(isocitrato)platinum(II).
Cancer Res. 1984 Sep;44(9):3736-43.
7
Mutagenic activity of nitrosourea antitumor agents.亚硝基脲类抗肿瘤药物的诱变活性。
J Natl Cancer Inst. 1980 Jul;65(1):149-54.
8
cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.顺式二氯(2-甲基吡啶)氨铂(II)(AMD473),一种新型空间位阻铂配合物:小鼠体内活性、毒理学及药代动力学
Clin Cancer Res. 1997 Nov;3(11):2063-74.
9
Unexpected genetic toxicity to rodents of the N',N'-dimethyl analogues of MNU and ENU.MNU和ENU的N',N'-二甲基类似物对啮齿动物产生意外的遗传毒性。
Environ Mol Mutagen. 1996;27(3):202-10. doi: 10.1002/(SICI)1098-2280(1996)27:3<202::AID-EM5>3.0.CO;2-G.
10
Antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugated with polyglutamic acid and its derivative.1-β-D-阿拉伯呋喃糖基胞嘧啶与聚谷氨酸及其衍生物的抗肿瘤活性
Cancer Res. 1984 Jan;44(1):25-30.